InsiderTrades

Form 4 for MPLT MapLight Therapeutics, Inc.

Accepted 2026-04-17 16:05:12 ET · period of report 2026-04-15 · accession 0002021233-26-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2026-04-17 16:05 2026-04-15+ MPLT Foff Erin Pennock Chief Medical Off S - Sale $27.03 -3,213 400.8K -0.8% -$86.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Voting Common Stock 2026-04-15 S D 2,044 $26.84 401,946 D — — (F1) Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.33 to $27.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5). (F3) Includes 155 shares acquired under the Issuer's stock purchase plan on March 31, 2026.
2 Common Voting Common Stock 2026-04-16 S D 288 $27.01 401,658 D — — (F1) Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive.
3 Common Voting Common Stock 2026-04-16 S D 881 $27.49 400,777 D — — (F1) Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. (F5) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive.